American Well Corp
NYSE:AMWL

Watchlist Manager
American Well Corp Logo
American Well Corp
NYSE:AMWL
Watchlist
Price: 5.59 USD 8.54% Market Closed
Market Cap: $91.5m

American Well Corp
Investor Relations

American Well Corp. engages in the provision of online healthcare services. The company is headquartered in Boston, Massachusetts and currently employs 1,035 full-time employees. The company went IPO on 2020-09-17. The firm platform is a digital delivery of care for healthcare in the United States. The company believes that digital care delivery solutions equip its health system, health plan, and clients, including government clients, with the tools to enable new models of care for their patients and members. The firm offers a platform to support all telehealth needs, from urgent to acute and post-acute care, as well as chronic care management and healthy living. The company offers digital care programs for approximately 55 health plans, which have more than 80 million covered lives, as well as approximately 150 of the nation's health systems, encompassing hospitals. The company also offers a full range of management software, clinical workflows, and system integrations to deliver care across many modalities, including video, phone, and secure messaging. Its Carepoint portfolio includes the C500, Touchpoint Table, and Hospital TV.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 12, 2026
AI Summary
Q4 2025

Revenue Decline: Amwell reported Q4 revenue of $55.3 million, down 22.1% year-over-year due to contract step-downs and a refocus on core markets.

Subscription Shift: Subscription revenue grew as a share of total revenue to 53% for 2025, up from 45% in 2024, reflecting a move to more predictable SaaS-based income.

Cost Reduction: The company reduced operating expenses by 30.7% year-over-year and cut both net loss and adjusted EBITDA losses by about $100 million for the full year.

Gross Margin Pressure: Q4 gross margin was 51.2%, down 280 basis points year-over-year, but management expects improvement as higher-margin SaaS revenue grows.

Cash and Liquidity: Amwell ended the year with $182 million in cash and marketable securities and no debt.

2026 Guidance: Full-year 2026 revenue is expected to be $195–205 million, with adjusted EBITDA loss between $24 million and $18 million and a goal of reaching cash flow breakeven in Q4.

Contract Renewals: Over 15 payer contract renewals in 2025 secured most existing subscription revenue, reducing renewal risk in 2026 except for the important DHA contract.

Platform Focus: The business has been streamlined to one core tech platform, divesting non-core assets to drive higher quality, stickier, and higher-margin revenue.

Key Financials
Revenue
$55.3 million
Subscription Revenue
$28.8 million
Subscription Revenue Share
53%
AMG Visit Revenue
$23.7 million
Paid AMG Visits
340,000
Total Platform Visits
1 million
Gross Profit
$28.3 million
Gross Margin
51.2%
Operating Expenses
$55.3 million
Operating Expenses as % of Revenue
96.7%
Adjusted EBITDA
loss of $10.3 million
Net Loss
$25.2 million
Cash Burn
$19 million in Q4
Cash and Marketable Securities
$182 million
Debt
no debt
Earnings Call Recording
Other Earnings Calls

Management

Dr. Ido Schoenberg M.D.
Chairman & CEO
No Bio Available
Dr. Roy Schoenberg M.D., M.P.H.
Executive Vice Chairman
No Bio Available
Ms. Phyllis I. Gotlib
President of Amwell International
No Bio Available
Mr. Vukasin Paunovich
Executive Vice President of Enterprise Platforms
No Bio Available
Ms. Kathy Weiler
Executive VP and Chief Commercial & Growth Officer
No Bio Available
Mr. Mark J. Hirschhorn CPA
Chief Financial Officer
No Bio Available
Mr. Kurt Knight
Chief Operating Officer
No Bio Available
Mr. Paul Francis McNeice
Vice President of Accounting
No Bio Available
Ms. Sue Dooley
Head of Investor Relations
No Bio Available
Mr. Bradford F. Gay J.D.
Senior VP & General Counsel
No Bio Available

Contacts

Address
MASSACHUSETTS
Boston
75 State Street, 26Th Floor
Contacts
+16172053500.0
business.amwell.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett